by Amaia Muñoz Lopetegi I am truly satisfied with the fellowship experience, which has been absolutely enriching for my professional and personal development as a neurologist, both in the clinical side and in research. I am quite happy with… Continue Reading
The new CME article December 2017: “Characterization of isolated amyloid myopathy” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer the questions! All e-learning activities are free-of-charge for EAN registered users.
Answer… Continue Reading
The new CME article August 2017: “Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies – a national cohort study” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer… Continue Reading
Rudolf Martini, Würzburg, Germany, was the first speaker of this session and talked about opportunities for treatment of CMT diseases. At the moment, there is no cure for these genetic neuropathies. Studies (mouse and human) with many substances studied, such as ascorbic acid, progesterone antagonist, curcumin, neurotrophin 3, carried out without success.